If you are a student, recent graduate or alumni interested in exploring a career in the biotechnology, pharmaceutical and life sciences industries, you are in the right place! Register today to start your job search and be contacted by employers nationwide looking for you! It only takes a few minutes and you will be on your way to the perfect job!
Tuesday, February 16, 2010
As the tough economy forces biotechs to halt projects or declare bankruptcy, the industry is looking to a provision in the Senate’s version of the healthcare reform bill to keep research going.
The so-called Therapeutic Tax Credit, backed by Sen. Robert Menendez (D-NJ), is intended to help companies with fewer than 250 employees pay the salaries of their scientists, continue research and even hire workers to help the companies develop new medicines, according to the Star Ledger.
The program would require companies to compete for money by submitting research projects to the federal Treasury Department. The companies would have to show how their projects lower healthcare costs or meet an unmet medical need. Tax credits will cover as much as 50 percent of the R&D expenses generated by the submitted project. The program is capped at $1 billion for the two-year period, according to the Ledger article.Read Full Article
posted in: News, Washington DC
Phoenix • Tucson • Palm Springs • Sacramento • San Diego • San Francisco • San Jose • Denver • Jacksonville • Miami • Orlando • Tampa • Atlanta • Chicago • Indianapolis • Kansas City • Louisville • New Orleans • Boston • Baltimore • Detroit • Grand Rapids • Minneapolis • Charlotte • Raleigh • Omaha • Atlantic City • Las Vegas • Reno • Buffalo • New York City • Cincinnati • Cleveland • Toledo • Tulsa • Portland • Philadelphia • Pittsburgh • Myrtle Beach • Memphis • Nashville • Austin • Dallas • Houston • San Antonio • Salt Lake City • Richmond • Seattle • Spokane
